Jun 08, 2021 / 05:20PM GMT
Amit Hazan - Goldman Sachs Group, Inc., Research Division - Equity Analyst
Okay. And I think we're back live here at the Goldman Sachs Healthcare conference. I'm Amit Hazan, the medical technology analyst at Goldman. And we're really excited to have, as our next conversation in med tech, Edwards Lifesciences, and we've got coming back again this year, Scott Ullem, the Chief Financial Officer, to walk us through the conversation.
So first and foremost, Scott, thanks so much for joining us again this year.
Scott B. Ullem - Edwards Lifesciences Corporation - Corporate VP & CFO
Yes, it's our pleasure. Good to be here, Amit.
Questions and Answers:
Amit Hazan - Goldman Sachs Group, Inc., Research Division - Equity AnalystYes. Great. Great to see you. So Scott, we've been starting these conversations by kind of wanting to get the COVID piece out of the way. It's still important and top of mind for a lot of investors. And so I don't know what you can say, but just maybe give us an update, to the extent
Trustpilot
